MedPath

Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision

Completed
Conditions
Rectal Neoplasms
Interventions
Other: injection of indigo carmine
Registration Number
NCT04455737
Lead Sponsor
Walter Brunner
Brief Summary

Background: An exact lymph node staging is essential in the treatment of rectal cancer.

Objective: The aim of this study was to assess the effect of indigo carmine injection on the number of retrieved and positive lymph nodes after transanal total mesorectal excision (taTME).

Design: This is a retrospective, non-randomised study. Settings: This study was conducted at a tertiary hospital by a multidisciplinary team.

Patients: Between 2013 and 2019, patients undergoing transanal total mesorectal excision were analysed. Patients with indigo carmine injection (intervention group) were compared to those without (control group).

Interventions: Transanal total mesorectal excision was performed with or without ex vivo intra-arterial indigo carmine injection.

Main Outcome Measures: The number of retrieved and positive lymph nodes was the primary outcome measure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
189
Inclusion Criteria
  • elective, oncologic rectum resection in TaTME technique for proven or highly suspected rectal cancer.
Exclusion Criteria
  • abdominoperineal resection
  • extended colon resection
  • previous surgery of the rectum, the left colon or the mesocolon/-rectum
  • patients rejecting retrospective data analysis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with indigo carmine stained specimeninjection of indigo carmineSpecimen which underwent pathologic work-up after ex vivo indigo carmine injection into the inferior mesenteric artery after transanal total mesorectal excision.
Primary Outcome Measures
NameTimeMethod
retrieved lymph nodes1 - 7 days after surgery

number of lymph nodes retrieved by pathologist from the specimen

Secondary Outcome Measures
NameTimeMethod
N stage1 - 7 days after surgery

N stage according TNM version 7

survival5 years

overall survival

positive lymph nodes1 - 7 days after surgery

number of lymph nodes with microscopic tumor infiltration

Trial Locations

Locations (1)

Department of General, Visceral, Endocrine and Transplantation Surgery, Cantonal Hospital St. Gallen

🇨🇭

Rorschach, Switzerland

© Copyright 2025. All Rights Reserved by MedPath